Pharmacy Advantage Specialty Pharmacy is a URAC accredited, Michigan-based specialty pharmacy that provides compassionate care and comprehensive Medication Therapy Management Programs (MTMPs) to patients with acute and chronic conditions. The company offers core programs including Oncology, Hepatitis B and C, Multiple Sclerosis, Growth Hormone Deficiency, Organ Transplant, Infertility, Rheumatoid Arthritis, Crohn’s Disease, and other Autoimmune Disorders. Incorporated specialty services encompass free next-day prescription delivery, benefits investigation, financial assistance programs, and disease-specific clinical counseling, aiming to ensure appropriate medication utilization, adherence, and routine preventative measures to limit adverse reactions.
Incorporated in 2003, Pharmacy Advantage operates in the biotechnology and health care industries. The company's commitment to navigating the persistent and confusing changes in the health care model sets it apart. The highly-trained team continuously seeks to increase customer satisfaction by furnishing paramount service with a personalized touch, ensuring a healthy dose of compassion.
As of the current available data, there is no information on the last investment or the investors involved in the last investment round for Pharmacy Advantage Specialty Pharmacy.